Elevated blood sugar doesn’t just show up as a number on a glucose meter — at the cellular level, excess glucose reacts directly with proteins, fats, and even genetic material, forming compounds called advanced glycation end products (AGEs) that have been linked to accelerated aging, cardiovascular disease, nerve damage, vision loss, and kidney complications. A specific, more absorbable form of a century-old vitamin appears to interrupt this process directly — and it’s often overlooked in mainstream conversations about blood sugar. (Based on the insights of Dr. Mitch Rice)
Key Takeaways
- Elevated blood sugar causes glucose to bind to proteins, fats, and DNA, forming AGEs — compounds linked to accelerated aging, cardiovascular disease, and diabetes complications — even in people without diabetes.
- Thiamine (vitamin B1) supports an enzyme that redirects glucose away from the pathway that forms AGEs, but people with elevated blood sugar often run low on it due to increased need and impaired kidney retention.
- Benfotiamine, a fat-soluble form of thiamine, absorbs far better than standard B1 and has decades of research and clinical use (particularly in Europe) behind it for diabetic nerve damage.
- Research dosing is typically 150–300 mg of benfotiamine daily, split into two doses — standard multivitamin B1 doesn’t come close to this.
- A small, early-stage pilot trial found benfotiamine slowed cognitive decline in people with mild Alzheimer’s over 12 months — promising but not yet proof it treats or prevents the disease.
What’s Actually Happening When Blood Sugar Runs High
When glucose levels are elevated, whether in someone with diagnosed diabetes or not, excess glucose doesn’t simply circulate harmlessly. Researchers describe this process as glycation: glucose molecules bind to proteins, fats, and DNA in places they don’t belong, disrupting normal function wherever they attach and forming AGEs. Research has linked elevated AGEs to accelerated aging and cardiovascular disease, and to diabetes-specific complications like nerve damage, vision loss, and kidney disease. One study of patients experiencing acute coronary syndrome (the events leading up to a heart attack) found that higher levels of these compounds independently predicted death and further heart disease. Importantly, this glycation process isn’t limited to people with diabetes — it happens in anyone with elevated blood sugar, including people within a normal range, just at a slower pace.
The Vitamin That Interrupts This Process
Thiamine (vitamin B1) is required for an enzyme called transketolase, whose job is to redirect certain glucose byproducts down a different metabolic route — the pentose phosphate pathway — away from the pathway that generates AGEs. Here’s the complication: people with diabetes or chronically elevated blood sugar actually need more thiamine, while at the same time, elevated glucose impairs the kidneys’ ability to retain it. This creates a situation where the people who most need thiamine to protect against glycation are often functionally deficient in it, frequently without obvious symptoms pointing to the cause.
Standard thiamine supplements are water-soluble and don’t absorb particularly well, especially at higher doses. Benfotiamine is a fat-soluble form of thiamine that crosses cell membranes more efficiently, and research has found it raises blood levels of vitamin B1 substantially higher than standard thiamine supplementation.
What the Research Shows
Laboratory research testing benfotiamine on cells exposed to high glucose concentrations found that it blocked multiple well-documented pathways of glucose-related cellular damage at once, including the pathway that generates AGEs. In clinical research involving people with type 2 diabetes, benfotiamine has been shown to meaningfully reduce AGE formation and help prevent vascular endothelial dysfunction (damage to the lining of blood vessels), a common complication in diabetic patients. For decades, benfotiamine has been used by physicians in parts of Europe specifically to treat diabetic neuropathy (nerve damage from chronically elevated blood sugar) and to help guard against broader diabetes complications affecting vision, kidney function, and cardiovascular health.
There’s also emerging research connecting AGEs to cognitive decline. A small, randomized, placebo-controlled Phase IIa pilot trial testing benfotiamine in people with mild Alzheimer’s disease found reduced AGE levels alongside slower cognitive decline over 12 months compared to placebo. This was an early-stage pilot trial with a small number of participants — a meaningful signal worth following, but not yet confirmation that benfotiamine treats or prevents Alzheimer’s disease.
How It’s Typically Used
Research studies have generally used benfotiamine in the range of roughly 150–300 mg daily, often split into two doses. This is meaningfully different from the standard thiamine dosing found in most multivitamins, which doesn’t achieve comparable intracellular concentrations. If you’re considering a supplement, look specifically for one labeled “benfotiamine” rather than simply “vitamin B1” or “thiamine,” since the two forms behave differently in the body. Benfotiamine has generally been well tolerated in research with a minimal side effect profile, though as with any supplement, it’s worth discussing with your doctor first, particularly if you take other medications or have kidney concerns.
Why a Single Lab Number Doesn’t Tell the Whole Story
Blood sugar management is often tracked almost entirely through hemoglobin A1c, which reflects average blood sugar over roughly three months. What it doesn’t capture is how much cellular damage occurred during that period. Two people could have an identical A1c reading, yet one may have adequate thiamine actively limiting glycation reactions with each blood sugar rise, while the other, running thiamine-deficient, experiences more unchecked glycation with those same glucose spikes — producing a very different amount of underlying tissue damage despite an identical lab result. This is a reasonable argument for why addressing thiamine status is worth considering as part of managing blood sugar health, alongside (not instead of) standard monitoring and treatment.
Frequently Asked Questions
Is benfotiamine the same as the vitamin B1 in my multivitamin?
No. Standard thiamine (vitamin B1) is water-soluble and doesn’t absorb especially well at higher doses. Benfotiamine is a fat-soluble form that crosses cell membranes more efficiently and reaches meaningfully higher blood levels. If you’re looking for the form used in this research, check that the label specifically says “benfotiamine,” not just “vitamin B1” or “thiamine.”
Does this only matter if I have diabetes?
No — the glycation process that forms AGEs happens in anyone with elevated blood sugar, including people with blood sugar in the normal-but-higher-end range, just at a slower pace than in diabetes. That said, people with diabetes or chronically elevated blood sugar tend to need more thiamine while also losing more of it through the kidneys, making a deficiency more likely in that group specifically.
Does benfotiamine prevent or treat Alzheimer’s disease?
Not according to current evidence. One small, early-phase pilot trial found a slower rate of cognitive decline over 12 months in people with mild Alzheimer’s taking benfotiamine compared to placebo. That’s a promising early signal, not confirmation of a treatment effect — larger trials would be needed to establish that.
How much benfotiamine do studies typically use?
Most research has used roughly 150–300 mg daily, often split into two doses. This is well above what you’d get from standard thiamine in a typical multivitamin, which is part of why benfotiamine specifically (not just any B1 supplement) is what’s referenced in this research.
Things to Discuss With Your Doctor
- ☐ Your current blood sugar status (fasting glucose, A1c) and whether thiamine status is relevant for you
- ☐ Whether benfotiamine specifically (not standard thiamine) might be worth adding, and at what dose
- ☐ Any interactions with current medications, especially if you have kidney disease
- ☐ Continuing standard blood sugar monitoring and treatment — this is a complement, not a replacement
- ☐ Checking the supplement label specifically says “benfotiamine,” not just “vitamin B1”
This article is for general educational purposes and is not a substitute for personalized medical advice. Speak with a qualified healthcare provider before starting any new supplement, especially if you have diabetes, kidney disease, or take other medications.